PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 8, 2026Immunology and Cell Biology0 citations

Cytosolic delivery of bacterial metabolites by riboflavin transporters promotes MR1 antigen presentation and MAIT cell recognition

View Full Paper
SCSebastian Cruz‐GomezPeter Doherty InstituteHLHui Jing LimPeter Doherty InstituteBNBrunda NijagalThe University of Melbourne

Key Points

  • This research aims to understand how MR1 presents microbial vitamin B-related metabolite antigens to MAIT cells.
  • Investigated the cytosolic pathways for bacterial vitamin B metabolite (VitBAg) transportation.
  • Assessed the role of riboflavin transporters in enhancing MR1-mediated antigen presentation.
  • Evaluated the impact of eliminating specific riboflavin carriers on VitBAg presentation.
  • Riboflavin transporters significantly enhance MR1 antigen presentation to MAIT cells.
  • VitBAg presentation is inhibited by riboflavin, indicating competitive interaction.
  • Even without specific riboflavin carriers, cells demonstrate alternative mechanisms for internalizing MR1 ligands.

Abstract

Abstract Major histocompatibility complex class I‐related protein 1 (MR1) presents microbial Vitamin B‐related metabolite antigens (VitBAg) at the cell surface to activate mucosal‐associated invariant T (MAIT) cells. Precisely how antigen‐presenting cells capture these MR1 ligands is not known. Here, we show that the most effective route for presentation of bacterial VitBAg involves passage through the cytosol. Consistent with structural similarities with riboflavin, we find that VitBAg presentation is inhibited by riboflavin. We further show that riboflavin carriers transport VitBAg into cells and enhance MR1 antigen presentation to MAIT cells. However, elimination of specific riboflavin carriers does not ablate VitBAg presentation, indicating cells possess redundant mechanisms to internalize this family of MR1 ligands. Our findings provide new insights into the intracellular pathway used by VitBAg to bind MR1 molecules and identify potential approaches to boost MR1‐mediated MAIT cell responses for therapeutic benefits.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Cruz‐Gomez et al. (2026) studied this question.

synapsesocial.com/papers/69fd8021bfa21ec5bbf08832https://doi.org/10.1111/imcb.70130
Ask AI
Helpful
Bookmark
Share
View Full Paper